In recent decades, the epidemiology of invasive candidiasis (IC) has progressively changed
worldwide. This notably includes emergence of several Candida species. Although some …

Invasive fungal infections increase mortality and morbidity rates worldwide. The treatment of
these infections is still limited due to the low bioavailability and toxicity, requiring therapeutic …

Abstract The China Assessment of Antifungal Therapy in Hematological Disease study, the
first large-scale observational study of invasive fungal disease (IFD) in China, enrolled 1401 …

The burden of invasive fungal infections is alarming worldwide. The aim of this paper is to
review the published literature and evaluate the knowledge gap pertaining to studies on …

This stud y examined the epidemiology, risk factors, management, and outcome of invasive
fungal infection (IFI) in patients receiving chemotherapy for hematological malignancy in …

Objectives Microbiological strategies are necessary to help clinicians discontinue empirical
antifungal therapy in patients with suspected invasive candidiasis. Culture methods and …

The echinocandins—caspofungin, anidulafungin and micafungin—are semi-synthetic cyclic
hexapeptide antimicrobial agents with modified N-linked acyl lipid side chains which anchor …

Invasive fungal infection (IFI) is a significant global healthcare concern among critically ill
and immunocompromised patients. In Middle Eastern countries, IFI has been steadily …

Amphotericin B (AmB) is one of the most used drugs for the treatment of systemic fungal
infections; however, the treatment causes several toxic manifestations, including …

Aim Clinical practice guidelines (CPGs) have progressively become a popular tool for
making optimal clinical decisions. The literature shows that the poor quality of CPGs can …